Intercytex (ICX-RHY/Vavelta Asset) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Intercytex (ICX-RHY/Vavelta Asset) General Information

Description

A skin repair and rejuvenation product. The asset has been designed to improve the structure, function and appearance of skin damaged by medical conditions such as EB, scarring and associated scar contractures or the aging process.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Pharmaceuticals
Primary Office
  • Oaks Business Park, Innovation House
  • Crewe Road
  • Manchester M23 9QR
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intercytex (ICX-RHY/Vavelta Asset) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Intercytex (ICX-RHY/Vavelta Asset)‘s full profile, request access.

Request a free trial

Intercytex (ICX-RHY/Vavelta Asset) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Intercytex (ICX-RHY/Vavelta Asset)‘s full profile, request access.

Request a free trial